Ghrelin receptor (GHS-R1a) and its constitutive activity in somatotroph adenomas: a new co-targeting therapy using GHS-R1a inverse agonists and somatostatin analogs.
2014 · HAL (Le Centre pour la Communication Scientifique Directe) · 0 citations
Y
Yves Mear
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Yves Mear is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat